Compact, single-room proton therapy solution

TOKYO – Mitsubishi Electric Corporation (TOKYO:6503) will provide its proton beam therapy system for cancer treatment at the Hakuhokai Group Osaka Proton Therapy Clinic scheduled to open in April 2016.

The new system will feature a compact, single-room design that meets the growing global demand for more cost-effective proton therapy solutions. Mitsubishi Electric’s decades of experience in particle therapy systems will contribute to the increased availability of innovative, efficient systems in hospitals worldwide.

The proton beam therapy system from Mitsubishi Electric features the Universal Nozzle for operational efficiency and the high-dose-rate irradiation that can reduce the irradiation time. To obtain Japanese government approval of the new system in a timely manner, testing is now being performed at the Accelerator Test Facility in Mitsubishi Electric’s Kobe factory. Mitsubishi Electric will provide staff training and commissioning support to facilitate the early startup of treatment.

To date, eight of the 11 facilities now conducting particle therapy in Japan are using these systems. More than 16,000 patients have so far been treated at these facilities. The Hakuhokai Group order, which was preceded by a separate order two weeks earlier from Tsuyama Chuo Hospital in Okayama, Japan, will become the tenth installation of a Mitsubishi Electric particle therapy system.

The Mitsubishi Electric particle therapy system at Tsuyama Chuo Hospital will be part of a new treatment center expected to open in March 2016 that will be jointly operated with Okayama University

Related site: Advanced Magnetic and Medical Systems Marketing Department